About Trautec
Founded in 2015, Jiangsu Trautec Medical Technology Co., Ltd. is dedicated to the development and production of recombinant collagen-based biomaterials with the mission of developing recombinant collagen biomaterials.
The accumulated investment of the company is nearly 100 million yuan, and the production plant located in Changzhou, Jiangsu reaches 10,000 square meters. The company has an excellent technical team with independent intellectual property rights in the development of recombinant collagen. We will continue to expand the application of recombinant human-derived collagen products in high-end fields such as medicine, medical regeneration and medical aesthetics, and occupy the forefront of the industry, aiming to build a global leading company in recombinant human-derived collagen products!
More
NewsNews
-
2022-07-01Trautec's Recombinant Type XVII Collagen Wins Personal Care Industry Ringier Technology Innovation Award
創健醫療重組XVII型膠原榮獲個人護理品行業榮格技術創新獎歷時報名、初審、專家評核、大眾評選，創健醫療重組XVII型膠原脫穎而出，榮獲行業極具公信力的技術大獎——2022個人護理品行業「榮格技術創新獎」?！笜s格技術創新獎」由領先的工業資訊媒體榮格工業傳媒主辦，自2006年成功舉辦以來，以其公正、客觀的評選流程倍受業界關注，已逐漸成為業內極具專業性和影響力的行業評選。補充膠原引領功效型
Technology
Recombinant human collagen / patent No：ZL 2013 1 0033299.6
R&D TeamMore
Chief Scientist
Prof. Jiang XiaAssociate professor of the Chinese University of Hong KongProf. Xia, is the associate professor in chemistry (tenured) and life science department, he received his PhD in Stanford University and then conducted a postdoctoral research in California Institute of Technology. His engaged in the research on biochemistry, proteomic and enzyme engineering, focused on artificial organelles and polypeptide drugs and their application in synthetic biology and biomedicine, respectively. Prof. Xia’s research was strongly supported by the Research Grants Council, the Innovation and Technology Commission and the Food and Health Bureau in Hong Kong, financed by large listed pharmaceutical company.
Chief technology officer
Dr. Lei ZhangTechnic Director of UnicollagenDr. Zhang was PhD and Postdoc researcher on biochemistry in the University of Nottingham. In 2009, he has been awarded the title of provincial innovative and entrepreneurial talent by Jiangsu High-level innovative and entrepreneurial talent recruitment programme, selected to the Talent honorary project in Wujin of Changzhou. In 2018, he has obtained the title of the Leading Innovative Talent through the Longcheng Elite programme in Changzhou, and the provincial title of innovative and entrepreneurial Doctor through Jiangsu High-level innovative and entrepreneurial talent recruitment programme...
互聯網藥品信息服務資格證書